Learn More
InBios International, Inc. COVID-19/Flu A and B RespiraDX™ Rapid Self-Test

Description
COVID-19/Flu A and B RespiraDX™ Rapid Self-Test is intended for the qualitative detection and differentiation of influenza A, and influenza B nucleoprotein antigens and SARS-CoV-2 nucleocapsid antigen directly in anterior nasal swab samples from individuals with signs and symptoms of respiratory tract infection.
- FDA-cleared for in vitro diagnostic use
- For over-the-counter use
- Simultaneously detects 3 viruses (SARS-CoV-2, Flu Aand B)
- No repeat testing necessary
- Two result windows for easy readability
- Shallow nasal swab collection
- Suitable for 2+ years old. Swabbing should be performed by an adult for children aged 2 to 13. User must be aged 14 + to perform self test.
Specifications
Specifications
| CE Marker | No |
| Clia Complexity | Waived (OTC) |
| Detectable Analytes | COVID-19 |
| DoA Calibrators | No |
| Type | Rapid Test |
| Disposable | Single-use |
| Form | Swab |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.